Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● The company has a good ESG score relative to its sector, according to Refinitiv.


Strengths

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● The group's activity appears highly profitable thanks to its outperforming net margins.

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

● The opinion of analysts covering the stock has improved over the past four months.

● Consensus analysts have strongly revised their opinion of the company over the past 12 months.

● There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.

● The group usually releases upbeat results with huge surprise rates.


Weaknesses

● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.

● The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.

● The company is not the most generous with respect to shareholders' compensation.

● For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.

● For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.